Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Different Radiation Dose of Neoadjuvant Chemoradiation Followed by Surgery in Treating Patients with Locally Advanced, Resectable Thoracic Esophageal Cancer

NCT03381651 is registered in ClinicalTrials.gov with Zhejiang Cancer Hospital as lead sponsor.

NCT NCT03381651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03381651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Different Radiation Dose of Neoadjuvant Chemoradiation Followed by Surgery in Treating Patients with Locally Advanced, Resectable Thoracic Esophageal Cancer
Lead sponsor
Zhejiang Cancer Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 22, 2018
Completion date
February 22, 2023
Enrollment
147 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal carcinoma, neoadjuvant chemoradiotherapy, surgery